GlassScriptPhysician profile
Esther Lamb
NPI 1700917770
$10,845.84
in general payments reported to CMS, 2019-2025
51 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,000 · 2022: $2,358 · 2023: $3,290 · 2024: $846 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,234 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,234.18 |
| Education | $253.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $1,266.68 | 2021-2023 | Onivyde, Somatuline Depot |
| Exelixis INC. | $1,261.27 | 2023 | Cabometyx |
| Gilead Sciences, INC. | $629.15 | 2021-2024 | Trodelvy |
| Astellas Pharma US INC | $575.14 | 2021-2025 | Vyloy, Xospata |
| E.R. Squibb & Sons, L.L.C. | $552.87 | 2021-2025 | Opdivo, Opdualag |
| Eisai INC. | $446.63 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $439.02 | 2021-2023 | Alunbrig, Ninlaro |
| Merck Sharp & Dohme LLC | $410.57 | 2021-2023 | Keytruda, Lynparza |
| Incyte Corporation | $348.11 | 2021-2024 | Monjuvi, Pemazyre, Jakafi |
| Seagen INC. | $328.17 | 2021-2023 | Tukysa, Padcev, Adcetris |
| Astrazeneca Pharmaceuticals LP | $318.26 | 2021-2023 | Enhertu, Tagrisso, Imfinzi |
| Amgen INC. | $304.42 | 2021-2023 | Lumakras, Vectibix, Xgeva |
| Daiichi Sankyo INC. | $228.48 | 2021-2024 | Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $227.12 | 2021-2023 | |
| Tersera Therapeutics LLC | $222.90 | 2022-2023 | Xermelo, Quzyttir |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Lamb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.